All About TECVAYLI (Teclistamab)
HealthTree University: Know Your Therapy - All About TECVAYLI (Teclistamab)
TECVAYLI (Teclistamab) is a recently approved bispecific antibody. It works by attracting the innate immune system to come and kill the myeloma cells. In the video below you can find out and see exactly how TECVAYLI works. You can learn about the side effects and how to manage them. Additionally you can see how it is administered and the dosing schedule. Learn more about myeloma treatment at HealthTree University.
12.21 All About TECVAYLI (Teclistamab)
We’d like to thank our faculty who donated their time in creating these videos, including:
- Alfred Garfall, MD
Want more?
We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
- Myeloma Basics Part 1
- Myeloma Basics Part 2
- Myeloma Basics Part 3
- Myeloma Care Basics
- Building Your Healthcare Team
- Becoming an Empowered Patient
- Starting Myeloma Treatment
- Know Your Therapy
- Know Your Labs: Blood and Urine Testing in Myeloma
- Autologous Stem Cell Transplant (ASCT)
- Precursor Conditions
- Relapsed and Refractory MM Treatment
- Classes of Drugs
- Immunotherapy
- Myeloma Bone Disease
- Imaging in Myeloma
- MRD Testing
- Basic Genetics and Cancer Biology
- Myeloma Genetics
- Types of Genetic Testing in Myeloma
- Specific Myeloma Genetics Mutations and Risk
- Precision Medicine
- Financial Advice for Myeloma Patients and Their Families
- Geriatric Care and Myeloma
- Myeloma Kidney Disease
- Amyloidosis
- Myeloma Basics (Spanish)
- COVID-19 and Multiple Myeloma
- Complementary and Integrated Therapy
- Allogeneic Stem Cell Transplant
- Survivorship
- Clinical Trials
- Understanding Basic Blood tests
- Myeloma Vaccines
HealthTree University: Know Your Therapy - All About TECVAYLI (Teclistamab)
TECVAYLI (Teclistamab) is a recently approved bispecific antibody. It works by attracting the innate immune system to come and kill the myeloma cells. In the video below you can find out and see exactly how TECVAYLI works. You can learn about the side effects and how to manage them. Additionally you can see how it is administered and the dosing schedule. Learn more about myeloma treatment at HealthTree University.
12.21 All About TECVAYLI (Teclistamab)
We’d like to thank our faculty who donated their time in creating these videos, including:
- Alfred Garfall, MD
Want more?
We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
- Myeloma Basics Part 1
- Myeloma Basics Part 2
- Myeloma Basics Part 3
- Myeloma Care Basics
- Building Your Healthcare Team
- Becoming an Empowered Patient
- Starting Myeloma Treatment
- Know Your Therapy
- Know Your Labs: Blood and Urine Testing in Myeloma
- Autologous Stem Cell Transplant (ASCT)
- Precursor Conditions
- Relapsed and Refractory MM Treatment
- Classes of Drugs
- Immunotherapy
- Myeloma Bone Disease
- Imaging in Myeloma
- MRD Testing
- Basic Genetics and Cancer Biology
- Myeloma Genetics
- Types of Genetic Testing in Myeloma
- Specific Myeloma Genetics Mutations and Risk
- Precision Medicine
- Financial Advice for Myeloma Patients and Their Families
- Geriatric Care and Myeloma
- Myeloma Kidney Disease
- Amyloidosis
- Myeloma Basics (Spanish)
- COVID-19 and Multiple Myeloma
- Complementary and Integrated Therapy
- Allogeneic Stem Cell Transplant
- Survivorship
- Clinical Trials
- Understanding Basic Blood tests
- Myeloma Vaccines
about the author
Cynthia Chmielewski
Cynthia (Cindy) Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University. You can follow her on Twitter @myelomateacher
More on Treatment Advances
Trending Articles
Upcoming Events
Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.